214 related articles for article (PubMed ID: 35404103)
1. Retrospective Evaluation of Various Serological Assays and Multiple Parameters for Optimal Diagnosis of Lyme Neuroborreliosis in a Routine Clinical Setting.
van Gorkom T; Voet W; van Arkel GHJ; Heron M; Hoeve-Bakker BJA; Notermans DW; Thijsen SFT; Kremer K
Microbiol Spectr; 2022 Jun; 10(3):e0006122. PubMed ID: 35404103
[TBL] [Abstract][Full Text] [Related]
2. The Usefulness of Two CXCL13 Assays on Cerebrospinal Fluid for the Diagnosis of Lyme Neuroborreliosis: a Retrospective Study in a Routine Clinical Setting.
van Gorkom T; van Arkel GHJ; Heron M; Voet W; Thijsen SFT; Kremer K
J Clin Microbiol; 2021 Aug; 59(9):e0025521. PubMed ID: 34132584
[TBL] [Abstract][Full Text] [Related]
3. Discriminating between Lyme neuroborreliosis and other central nervous system infections by use of biomarkers CXCL13 and IL-6.
Leth TA; Dessau RB; Møller JK
Ticks Tick Borne Dis; 2022 Sep; 13(5):101984. PubMed ID: 35709639
[TBL] [Abstract][Full Text] [Related]
4. Lyme neuroborreliosis with antibodies in cerebrospinal fluid but not in serum.
Zomer TP; Bruinsma R; van Samkar A; Vermeeren YM; Wieberdink RG; van Kooten B; van Bemmel T
Eur J Neurol; 2023 Mar; 30(3):741-744. PubMed ID: 36371644
[TBL] [Abstract][Full Text] [Related]
5. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].
Rupprecht TA; Lechner C; Tumani H; Fingerle V
Nervenarzt; 2014 Apr; 85(4):459-64. PubMed ID: 24682168
[TBL] [Abstract][Full Text] [Related]
6. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
[No Abstract] [Full Text] [Related]
7. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
[TBL] [Abstract][Full Text] [Related]
8. Specificity and Diagnostic Utility of Cerebrospinal Fluid CXCL13 in Lyme Neuroborreliosis.
Eckman EA; Clausen DM; Herdt AR; Pacheco-Quinto J; Halperin JJ
Clin Infect Dis; 2021 May; 72(10):1719-1726. PubMed ID: 32221538
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I
APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis - a pilot study.
Tjernberg I; Johansson M; Henningsson AJ
Clin Chem Lab Med; 2019 Nov; 57(12):2008-2018. PubMed ID: 31199760
[TBL] [Abstract][Full Text] [Related]
11. Positive intrathecal anti-Borrelia antibody synthesis: what are the implications for clinical practice? Clinical features and outcomes of 138 patients in a French multicenter cohort study.
Naudion P; Raffetin A; Zayet S; Klopfenstein T; Baux E; Martinot M; Piroth L; Caumes E; Chirouze C; Bouiller K
Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):441-452. PubMed ID: 36806057
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study.
Knudtzen FC; Nilsson AC; Hovius JW; Skarphedinsson S
Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1461-1470. PubMed ID: 32172371
[TBL] [Abstract][Full Text] [Related]
13. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
[TBL] [Abstract][Full Text] [Related]
14. Direct Molecular Detection and Genotyping of Borrelia burgdorferi Sensu Lato in Cerebrospinal Fluid of Children with Lyme Neuroborreliosis.
Barstad B; Quarsten H; Tveitnes D; Noraas S; Ask IS; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29467195
[TBL] [Abstract][Full Text] [Related]
15. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis.
Djukic M; Schmidt-Samoa C; Lange P; Spreer A; Neubieser K; Eiffert H; Nau R; Schmidt H
J Neurol; 2012 Apr; 259(4):630-6. PubMed ID: 21898139
[TBL] [Abstract][Full Text] [Related]
18. Lyme neuroborreliosis in Swedish children-PCR as a complementary diagnostic method for detection of Borrelia burgdorferi sensu lato in cerebrospinal fluid.
Skogman BH; Wilhelmsson P; Atallah S; Petersson AC; Ornstein K; Lindgren PE
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):1003-1012. PubMed ID: 33387122
[TBL] [Abstract][Full Text] [Related]
19. Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis.
Ziegler K; Rath A; Schoerner C; Meyer R; Bertsch T; Erbguth F; Bogdan C; Steinmann J; Held J
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32434781
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to decorin-binding protein B (DbpB) in the diagnosis of Lyme neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Int J Infect Dis; 2014 Nov; 28():160-3. PubMed ID: 25316329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]